The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Class A common shares of Circle Internet Group, Inc... Show more
CRCA is a single-stock leveraged exchange-traded fund (ETF) that seeks daily investment results, before fees and expenses, corresponding to two times (2x) the daily performance of the Class A common shares of Circle Internet Group, a digital-finance company best known for issuing the USDC stablecoin. Rather than holding a diversified basket, the fund gains exposure primarily through swap agreements and other derivatives, with the remainder of assets held in cash and short-term U.S. Treasury instruments.
The fund is non-diversified, holds roughly 15 positions, and carries a net expense ratio of 0.95%. Because it resets leverage daily, returns over periods longer than one day can diverge significantly from 2x the underlying stock's cumulative return — a phenomenon known as volatility decay. This structure means CRCA is a tactical trading tool intended for short holding periods, not a buy-and-hold vehicle, and it naturally magnifies both gains and losses in Circle's shares.
Over the trailing 30 days, CRCA declined approximately 27%, from about $17.63 to $12.81. The move was not gradual: the fund experienced pronounced daily swings, including a double-digit single-session decline as the underlying stock sold off on security and competitive concerns.
The three-month picture is strikingly different. From roughly $12.50 in late July, CRCA rallied toward a peak near $29 in early September before giving back the entire advance, finishing the period essentially flat at about $12.81. This round trip illustrates how the fund's daily rebalancing can erode value even when the underlying stock is little changed over a longer window, as volatility and daily resets compound against holders.
The recent decline largely reflects amplified weakness in Circle Internet Group, whose shares came under pressure from several overlapping forces. The most immediate shock was a security breach at Binance involving roughly $6.3 billion, disclosed in late October, after which Circle froze more than $800 million of USDC tied to the incident. While the freeze demonstrated USDC's compliance safeguards, it coincided with a broad crypto-sector selloff that dragged Circle and its peers lower.
Company-specific sentiment also deteriorated. Analysts at Mizuho reiterated an Underperform rating and cut their price target, warning that AI personal-assistant tools could steer users away from USDC toward higher-yielding, FDIC-insured bank accounts — a direct threat to Circle's reserve-income model. This bearish view landed against a backdrop of stalled crypto market-structure legislation, with the CLARITY Act's progress in the Senate weighing on sentiment earlier in the autumn.
Because Circle earns the overwhelming majority of its revenue from interest on the reserves backing USDC, declining reserve yields and any slowdown in USDC circulation directly compress earnings expectations. The 2x leverage in CRCA converted these single-stock declines into roughly double the percentage drawdown.
The broader three-month trend has been a sharp rally followed by an equally sharp reversal, leaving the fund near where it began the period. The early-quarter advance reflected optimism around stablecoin adoption, Circle's regulatory positioning, and the growth of USDC use cases in payments and AI-driven commerce. The fund peaked near $29 in early September before sentiment turned.
Three structural themes have since weighed on the position. First, the launch of Open USD, a rival stablecoin backed by a consortium including major payments and asset-management firms, intensified competition for Circle's core reserve-income business. Second, expectations that U.S. interest rates may drift lower reduce the yield Circle earns on its reserve assets. Third, sustained weakness across crypto-linked equities has kept institutional flows muted. These longer-term forces, combined with the fund's daily leverage reset, explain why the quarter ended roughly flat despite substantial interim volatility.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. Rather than reviewing holdings one at a time, users can set criteria to surface securities matching specific technical or fundamental profiles — a useful complement to manual research for leveraged and single-stock products like CRCA, where timing and volatility matter. Explore the AI Screener to build custom scans and identify candidates that match your criteria.
Several factors are likely to shape CRCA over the coming months. The most important is interest rates, since Circle's reserve income scales directly with short-term yields; any shift in Federal Reserve policy expectations flows through to earnings forecasts and, by extension, to this leveraged fund. Equally significant is USDC circulation, which depends on stablecoin adoption, competitive dynamics from Open USD, and the regulatory environment.
Investors should also monitor the progress of stablecoin legislation such as the CLARITY Act, the outcome of upcoming earnings reports, and broader crypto-market sentiment, which tends to move Circle in tandem with peers like Coinbase. Finally, the fund's own mechanics matter: daily resets and high volatility mean multi-day holding periods can produce returns that diverge materially from 2x the underlying stock, a risk that deserves close attention before entering any position.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
CRCA saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned negative. In 24 of the 24 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CRCA turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 8 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
The 10-day moving average for CRCA crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 2 of 2 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CRCA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +11.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRCA advanced for three days, in 50 of 57 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.
CRCA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Category Unknown